rs35942089

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001374357.1(GFM1):​c.-99A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,611,068 control chromosomes in the GnomAD database, including 135 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0089 ( 16 hom., cov: 33)
Exomes 𝑓: 0.011 ( 119 hom. )

Consequence

GFM1
NM_001374357.1 5_prime_UTR_premature_start_codon_gain

Scores

1
4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 8.87

Publications

6 publications found
Variant links:
Genes affected
GFM1 (HGNC:13780): (G elongation factor mitochondrial 1) Eukaryotes contain two protein translational systems, one in the cytoplasm and one in the mitochondria. Mitochondrial translation is crucial for maintaining mitochondrial function and mutations in this system lead to a breakdown in the respiratory chain-oxidative phosphorylation system and to impaired maintenance of mitochondrial DNA. This gene encodes one of the mitochondrial translation elongation factors. Its role in the regulation of normal mitochondrial function and in different disease states attributed to mitochondrial dysfunction is not known. [provided by RefSeq, Jul 2008]
LXN (HGNC:13347): (latexin) This gene encodes the only known protein inhibitor of zinc-dependent metallocarboxypeptidases. The encoded protein, latexin, downregulates the population size of hematopoietic stem cells. This protein is found to be downregulated in cancer cells because of promoter hypermethylation. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008831739).
BP6
Variant 3-158645674-A-G is Benign according to our data. Variant chr3-158645674-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137462.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00889 (1354/152320) while in subpopulation NFE AF = 0.014 (953/68030). AF 95% confidence interval is 0.0133. There are 16 homozygotes in GnomAd4. There are 647 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001374357.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GFM1
NM_024996.7
MANE Select
c.127A>Gp.Asn43Asp
missense
Exon 2 of 18NP_079272.4
GFM1
NM_001374357.1
c.-99A>G
5_prime_UTR_premature_start_codon_gain
Exon 2 of 18NP_001361286.1
GFM1
NM_001374359.1
c.-103A>G
5_prime_UTR_premature_start_codon_gain
Exon 2 of 16NP_001361288.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GFM1
ENST00000486715.6
TSL:1 MANE Select
c.127A>Gp.Asn43Asp
missense
Exon 2 of 18ENSP00000419038.1Q96RP9-1
GFM1
ENST00000464732.1
TSL:3
c.-99A>G
5_prime_UTR_premature_start_codon_gain
Exon 2 of 4ENSP00000417532.1C9JA25
GFM1
ENST00000867690.1
c.127A>Gp.Asn43Asp
missense
Exon 2 of 19ENSP00000537749.1

Frequencies

GnomAD3 genomes
AF:
0.00890
AC:
1354
AN:
152202
Hom.:
16
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00181
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.00452
Gnomad ASJ
AF:
0.0237
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00870
Gnomad FIN
AF:
0.00933
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0140
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00961
AC:
2416
AN:
251432
AF XY:
0.00990
show subpopulations
Gnomad AFR exome
AF:
0.00172
Gnomad AMR exome
AF:
0.00309
Gnomad ASJ exome
AF:
0.0204
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0109
Gnomad NFE exome
AF:
0.0138
Gnomad OTH exome
AF:
0.00912
GnomAD4 exome
AF:
0.0112
AC:
16352
AN:
1458748
Hom.:
119
Cov.:
30
AF XY:
0.0115
AC XY:
8325
AN XY:
725894
show subpopulations
African (AFR)
AF:
0.00150
AC:
50
AN:
33430
American (AMR)
AF:
0.00369
AC:
165
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0193
AC:
505
AN:
26106
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39672
South Asian (SAS)
AF:
0.00762
AC:
657
AN:
86190
European-Finnish (FIN)
AF:
0.0126
AC:
674
AN:
53412
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5764
European-Non Finnish (NFE)
AF:
0.0123
AC:
13675
AN:
1109170
Other (OTH)
AF:
0.0101
AC:
610
AN:
60288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
764
1527
2291
3054
3818
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00889
AC:
1354
AN:
152320
Hom.:
16
Cov.:
33
AF XY:
0.00869
AC XY:
647
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00180
AC:
75
AN:
41576
American (AMR)
AF:
0.00451
AC:
69
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
82
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00870
AC:
42
AN:
4826
European-Finnish (FIN)
AF:
0.00933
AC:
99
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0140
AC:
953
AN:
68030
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
67
134
201
268
335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0125
Hom.:
53
Bravo
AF:
0.00732
TwinsUK
AF:
0.0132
AC:
49
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.0145
AC:
125
ExAC
AF:
0.00982
AC:
1192
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0122
EpiControl
AF:
0.0100

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 (4)
-
-
3
not provided (3)
-
-
3
not specified (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.025
T
Eigen
Benign
-0.0059
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.0088
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
8.9
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.31
N
REVEL
Benign
0.23
Sift
Benign
0.65
T
Sift4G
Benign
0.33
T
Polyphen
0.0040
B
Vest4
0.68
MVP
0.61
MPC
0.28
ClinPred
0.056
T
GERP RS
5.4
Varity_R
0.34
gMVP
0.91
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35942089; hg19: chr3-158363463; COSMIC: COSV108045339; COSMIC: COSV108045339; API